Pages that link to "Item:Q2059113"
From MaRDI portal
The following pages link to Efficacy and toxicity monitoring via Bayesian predictive probabilities in phase II clinical trials (Q2059113):
Displaying 6 items.
- Bayesian predictive monitoring with bivariate binary outcomes in phase II clinical trials (Q1727847) (← links)
- Monitoring Clinical Trials Based on Predictive Probability of Significance (Q3201537) (← links)
- An optimal Bayesian predictive probability design for phase II clinical trials with simple and complicated endpoints (Q3299101) (← links)
- Monitoring late-onset toxicities in phase I trials using predicted risks (Q3526173) (← links)
- Monitoring futility and efficacy in phase II trials with Bayesian posterior distributions—A calibration approach (Q5208132) (← links)
- (Q5714616) (← links)